A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform

Recent treatments of leukemias with chimeric antigen receptor (CAR) expressing T cells underline their impressive therapeutic potential. However, once adoptively transferred into patients, there is little scope left to shut them down after elimination of tumor cells or in case adverse side effects o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Albert, Susann, Arndt, Claudia, Feldmann, Anja, Bergmann, Ralf, Bachmann, Dominik, Koristka, Stefanie, Ludwig, Florian, Ziller-Walter, Pauline, Kegler, Alexandra, Gärtner, Sebastian, Schmitz, Marc, Ehninger, Armin, Cartellieri, Marc, Ehninger, Gerhard, Pietzsch, Hans-Jürgen, Pietzsch, Jens, Steinbach, Jörg, Bachmann, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5414885/
https://ncbi.nlm.nih.gov/pubmed/28507794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1287246
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados